Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
9.66
-2.06 (-17.55%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Neurogene Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
136.59148.2182.0270.54
Short-Term Investments
175.8248.95--
Cash & Short-Term Investments
312.41197.1682.0270.54
Cash Growth
58.45%140.37%16.27%-
Other Receivables
0.650.60.990.79
Receivables
0.650.60.990.79
Prepaid Expenses
1.891.51.081.91
Other Current Assets
0.981.10.630.71
Total Current Assets
315.92200.3584.7273.96
Property, Plant & Equipment
18.4920.9524.5527.53
Other Long-Term Assets
1.311.27--
Total Assets
335.73222.57109.27101.49
Accounts Payable
1.342.60.635.63
Accrued Expenses
9.3916.765.164.35
Current Portion of Leases
32.60.70.61
Other Current Liabilities
1.431.020.170.27
Total Current Liabilities
15.1622.976.6510.86
Long-Term Leases
9.4312.373.994.6
Other Long-Term Liabilities
0.771.21--
Total Liabilities
25.3636.5510.6415.46
Common Stock
---0
Additional Paid-In Capital
572.67373.185.13.77
Retained Earnings
-262.3-187.15-150.84-95.65
Total Common Equity
310.38186.02-145.74-91.88
Shareholders' Equity
310.38186.0298.6386.03
Total Liabilities & Equity
335.73222.57109.27101.49
Total Debt
12.4314.974.695.21
Net Cash (Debt)
299.98182.1977.3365.34
Net Cash Growth
64.65%135.59%18.36%-
Net Cash Per Share
17.0839.12196.0116.13
Filing Date Shares Outstanding
14.9312.855.674.05
Total Common Shares Outstanding
14.8512.825.674.05
Working Capital
300.77177.3878.0763.1
Book Value Per Share
20.8914.51-25.72-22.68
Tangible Book Value
310.38186.02-145.74-91.88
Tangible Book Value Per Share
20.8914.51-25.72-22.68
Machinery
9.69.319.046.01
Construction In Progress
1.310.230.252.86
Leasehold Improvements
15.415.3815.315.29
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q